Phase 1 data support TNX-1500 as a potentially first-in-class, best-in-class, third-generation anti-CD40L monoclonal antibody for the prevention of kidney transplant rejection Phase 2 ...
Pacemakers are vital, life-saving technology held back by their limited battery life, but the solution to that problem may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results